Most cited papers from Recordati (France)

Recordati (France)

What are the most cited papers from Recordati (France)?

The most cited paper from Recordati (France) is "Renal receptors in the rat sensitive to chemical alterations of their environment." (G Recordati, Nicholas Moss, Simonetta Genovesi et al., 1980), with 119 citations. Next come "Renal chemoreceptors in the rat." (114) and "Latest Clinical Approaches in the Ocular Management of Cystinosis: A Review of Current Practice and Opinion from the Ophthalmology Cystinosis Forum" (53).

Published TypeFieldAccess

Showing 44 of 44 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Renal receptors in the rat sensitive to chemical alterations of their environment. G Recordati, Nicholas Moss, Simonetta Genovesi et al. · Circulation Research Open access	Mar 1980	119
2	Renal chemoreceptors in the rat. G Recordati, Nicholas Moss, L Waselkov · Circulation Research Open access	Oct 1978	114
3	Latest Clinical Approaches in the Ocular Management of Cystinosis: A Review of Current Practice and Opinion from the Ophthalmology Cystinosis Forum Susmito Biswas, Martha Lia Gaviria, Luísa Malheiro et al. · Ophthalmology and Therapy Open access	21 Sep 2018	53
4	Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-Related Pain: The EQUIMETH2 Trial (Methadone for Cancer-Related Pain) Philippe Poulain et al. · Journal of Pain and Symptom Management Open access	2 Oct 2016	33
5	Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride Hong Liang, Antoine Labbé, Christophe Baudouin et al. · British Journal of Ophthalmology Open access	27 Jun 2020	26
6	Neue Benzothiazine, II. 3.4‐Dihydro‐2H‐1.2‐benzothiazinon‐(3)‐1.1‐dioxid und 3.4‐Dihydro‐1H‐2.3‐benzothiazinon‐(4)‐2.2‐dioxid Enrico Sianesi, Riccardo Redaelli, Marco Bertani et al. · Chemische Berichte	Jun 1970	18
7	Über eine neue Synthese der 4‐Hydroxy‐cumarine Paolo Da Re, E. SANDRI · Chemische Berichte	May 1960	17
8	Postauthorization safety study of betaine anhydrous Ulrike Mütze et al. · Journal of Inherited Metabolic Disease Open access	31 Mar 2022	13
9	Efficacité et la tolérance de la lercanidipine ne sont pas liées à l'âge des patients hypertendus : étude AGATE Pascal Poncelet, Jean Ribstein, Luc Goullard et al. · Annales de Cardiologie et d Angéiologie	Jun 2004	12
10	Neue Benzothiazine, III. 3.4‐Dihydro‐1 H‐2.1‐, 3.4‐Dihydro‐2H‐1.2‐ und 3.4‐Dihydro‐1H‐2.3‐benzothiazin‐S.S‐dioxid Enrico Sianesi, Giuseppe Bonola, Roberto Pozzi et al. · Chemische Berichte	Jun 1971	11
11	Real‐world management of maple syrup urine disease (MSUD) metabolic decompensations with branched chain amino acid ‐free formulas in France and Germany: A retrospective observational study Pascale de Lonlay, Roland Posset, Ulrike Mütze et al. · JIMD Reports Open access	6 Mar 2021	10
12	Validation du score visuel prostatique en images SVPI dans l’évaluation des symptômes du bas appareil urinaire associés à une hyperplasie bénigne de la prostate (550 patients) A. Descazeaud, Patrick J. Coloby, Jean‐Louis Davin et al. · The French Journal of Urology	Mar 2017	9
13	Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description Paolo D’Agostino, Alan J. Kent, Eric Sharp et al. · Drugs in Context Open access	4 Aug 2020	8
14	The visual prostate symptom score is a simple tool to identify and follow up in general practice patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (a study with 1359 patients) A. Descazeaud, Patrick J. Coloby, Alexandre de la Taille et al. · La Presse Médicale	Jul 2018	7
15	Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT Study Sufin Yap, Delphine Lamireau, François Feillet et al. · Drugs in R&D Open access	10 Jan 2024	5
16	Matching-Adjusted Indirect Comparison of Osilodrostat Versus Metyrapone for the Treatment of Cushing’s Syndrome Conor Hickey, B. Gueron, Fabian Schmidt et al. · Advances in Therapy	29 May 2025	4
17	Ultraviolett‐spektroskopische Untersuchungen über 2.3‐Dihydro‐1H‐chinazolone‐(4) und tautomere Azomethine Giuseppe Bonola, Enrico Sianesi · Chemische Berichte	Nov 1969	4
18	Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α 1 and 5-HT 1A receptor ligand: an in vitro and computational study Silvia Franchini, Annamaria Baraldi, Claudia Sorbi et al. · MedChemComm Open access	23 Dec 2014	4
19	Evaluation of a new classification system for measuring the progression of ocular cystinosis: an analysis of 64 patients Hong Liang, Christophe Baudouin, Vincenzo Giordano · British Journal of Ophthalmology Open access	2 Oct 2024	3
20	7790 A Non-interventional, Multinational, Phase IV Study to Evaluate the Long-Term Safety and Efficacy of Osilodrostat in Patients with Endogenous Cushing's Syndrome (LINC 6): 1-Year Real-World Interim Analysis Irina Bancos, Eliza Brevoort Geer, Frédéric Castinetti et al. · Journal of the Endocrine Society Open access	Oct 2024	2
21	Über die Synthese der 3,6‐Dimethylflavoncarbonsäure‐(8) und ihres Piperidinoäthylesters Paolo Da Re, L. Verlicchi · Archiv der Pharmazie	1963	2
22	Évolution des symptômes du bas appareil urinaire sous silodosine : facteurs influençant la satisfaction des patients A. Descazeaud, Jean‐Louis Davin, Alexandre de la Taille et al. · The French Journal of Urology	3 Jan 2014	2
23	Notiz über die Reaktion von Diazoniumsalzen mit 5‐substituierten 8‐Hydroxy‐chinolinen Dante Nardi, A Tajana, ELENA MASSARANI · Chemische Berichte	Jun 1968	2
24	Validation d’une échelle visuelle analogique (EVA) en médecine générale, dans l’évaluation des symptômes du bas appareil urinaire (SBAU) associés à une hypertrophie bénigne de la prostate (HBP) Patrick J. Coloby, J.-L. Davin, Alexandre de la Taille et al. · The French Journal of Urology	29 Oct 2014	2
25	From Molecular Understanding and Pathophysiology to Disease Management; A Practical Approach and Guidance to the Management of the Ocular Manifestations of Cystinosis Hong Liang, Christophe Baudouin, Bénédicte Dupas et al. · International Journal of Molecular Sciences Open access	25 Aug 2025	1
26	Standards of Care for Medical Management of Acromegaly in Pituitary Tumor Centers of Excellence (PTCOE) A Giustina, Meliha Melin Uygur, Stefano Frara et al. · Research Square PreprintOpen access	18 Mar 2024	1
27	655 Tumor micro-environment shift induced by topical chlormethine in early-stage mycosis fungoides by flow cytometry of interstitial fluid S. Wind, S. Assil, K. Quint et al. · Journal of Investigative Dermatology Open access	17 Apr 2023	1
28	Intérêt d’une évaluation systématique du traitement des symptômes du bas appareil urinaire dans la prise en charge d’une hypertrophie bénigne de la prostate en médecine générale (1380 patients) — Étude EVALURO A. Descazeaud, Patrick J. Coloby, Alexandre de la Taille et al. · The French Journal of Urology	18 Jan 2019	1
29	Intérêt d’une évaluation systématique du traitement des symptômes du bas appareil urinaire dans la prise en charge d’une hypertrophie bénigne de la prostate en médecine générale A. Descazeaud, Patrick J. Coloby, Alexandre de la Taille et al. · The French Journal of Urology	Nov 2018	1
30	Notiz über N‐[2‐Hydroxy‐äthyl]‐N‐benzoyl‐anilin und N‐[2‐Benzoyloxy‐äthyl]‐anilin Dante Nardi, Claudio Palmeri · Chemische Berichte	Sep 1970	1
31	Is masked hypertension an artefact due to the blood pressure measurement method and threshold effects? What is the true prevalence of masked hypertension? Pascal Poncelet, Pierre Clerson, Jean Ribstein et al. · Journal of Hypertension	7 Jul 2005	1
32	Lercanidipine, Enalapril, and Their Combination in the Treatment of Elderly Hypertensive Patients Juan García Puig, Carlos Calvo, Olavi J. Luurila et al. Book chapter	16 Jul 2007	1
33	Real world experience of carglumic acid for methylmalonic and propionic acidurias: the second interim analysis of the multicentre observational PROTECT study Sufin Yap, Elena Procopio, Alessandro Rossi et al. · Orphanet Journal of Rare Diseases Open access	3 Aug 2026	0
34	Management of acute metabolic decompensation in maple syrup urine disease: guidance based on international clinical practice Aude Servais, Marie Therese Abi-Wardé, Jean-Baptiste Arnoux et al. · Orphanet Journal of Rare Diseases Open access	6 Jun 2026	0
35	Impact of Osilodrostat on Health‐Related Quality of Life in Cushing's Disease: Analysis of Patient‐Reported Outcomes From the Phase III LINC 3 and LINC 4 Clinical Trials John D C Newell-Price, Beverly M. K. Biller, Maria Fleseriu et al. · Clinical Endocrinology Open access	Jun 2026	0
36	2201P A real-life observational study of cancer pain management with methadone in patients inadequately relieved by other level 3 opioids (DUNE study) Gisèle Chvetzoff, Philippe Poulain, I. Krakowski et al. · Annals of Oncology Open access	Sep 2025	0
37	SUN-054 Long-Term, Real-World, Safety and Effectiveness of Osilodrostat In Patients With Pituitary and Non-Pituitary Cushing’s Syndrome: 2-Year Interim Data From LINC 6 Irina Bancos, Frédéric Castinetti, Eliza Brevoort Geer et al. · Journal of the Endocrine Society Open access	Oct 2025	0
38	EE67 Cost-Effectiveness of Pasireotide Long-Acting Release in Acromegaly: Systematic Literature Review Grzegorz Binowski, Frank E. Schmidt, M Bronikowska et al. · Value in Health ReviewOpen access	Dec 2024	0
39	PRO2 REAL WORLD LONGITUDINAL HEALTHCARE RESOURCE UTILIZATION FOR PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) Barbara L. Blaylock, Jean Epstein, Fabian Schmidt et al. · Value in Health Open access	May 2020	0
40	Allowing Methadone’s Prescription To General Practitioners: A Positive Impact on The French Healthcare Insurance Expenditures I. Berard, F. Benazet, Sanford N. Cohen et al. · Value in Health Open access	Oct 2017	0
41	EFFICACY AND SAFETY OF LERCANIDIPINE ARE NOT AGE-DEPENDENT. AGATE STUDY Pascal Poncelet, Pierre Clerson, Jean Ribstein et al. · Journal of Hypertension	Jun 2004	0
42	Attitude des patients face à la proposition du pharmacien de substituer un générique à un omeprazole de marque François‐André Allaert, Haris Ćatović, Catherine Scart‐Grès · Revue du Rhumatisme	19 Oct 2006	0
43	Observatoire des patients présentant une hypertrophie bénigne de la prostate (HBP), traités par la silodosine : corrélations entre les symptômes urinaires, les troubles du sommeil et la qualité de vie des patients Patrick J. Coloby, Jean‐Louis Davin, Alexandre de la Taille et al. · The French Journal of Urology	29 Oct 2013	0
44	Validation en médecine générale d’un score visuel prostatique en images (SVPI), dans l’évaluation des symptômes du bas appareil urinaire (SBAU) associés à une hypertrophie bénigne de la prostate (HBP) A. Descazeaud, Patrick J. Coloby, J.-L. Davin et al. · The French Journal of Urology	29 Oct 2014	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.